Aristopin (Atropine 0.01%) is an anticholinergic drug. Aristopin is indicated to control myopia progression in pediatric patients (4-14 years).
Aristopin (Atropine 0.01) is an anticholinergic drug. Aristopin O/Sol effectively slows the progression of childhood myopia, as evidenced by clinical studies and endorsements from leading ophthalmology organizations. With its low-dose 0.01% Atropine formulation, Aristopin minimizes common side effects, making it suitable for long-term use in children. The duration of treatment with Aristopin (Atropine 0.01%) O/Sol, can vary depending on the individual child's response and the progression of their myopia. Generally, the treatment is recommended for a minimum of two years. However, it can be continued up to the age of 12 or until the child's eye growth stabilizes.
Aristopin Ophthalmic Solution: Each ml contains Atropine Sulfate USP 0.1 mg.
Aristopin is indicated to control the progression of myopia in paediatric patients (4-14 years).
One drop topically in eye(s) once at night.
Persons with glaucoma or a tendency toward glaucoma, and with hypersensitivity to belladonna alkaloids.
• For ophthalmic use only.
• Excessive use may produce symptoms of systemic atropine poisoning.
• Only paediatric use.
• May be associated with a stinging sensation on instillation.
• May cause allergy (itch, irritation, and redness), blurring of near vision, and glare in some children.
Atropine Ophthalmic Solution may interact with monoamine oxidase inhibitors (MAOIs).
Aristopin Ophthalmic Solution: Each LDPE dropper bottle contains 5 ml Sterile Eye Drops.
FR
DE